Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 1Phase 1/2 1

Status

Recruiting 3Active not recruiting 3

Sponsor Class

OTHER 3NIH 2OTHER_GOV 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Gastrointestinal Neoplasms 3Colorectal Neoplasms 2Colorectal Neoplasms, Hereditary Nonpolyposis 1Clinical Stage III Gastric Cancer AJCC v8 1

Interventions

Specimen Handling 613pembrolizumab 583Magnetic Resonance Spectroscopy 543Carboplatin 430Cyclophosphamide 380Cisplatin 377Biopsy 366Paclitaxel 314Nivolumab 312Gemcitabine 308Radiotherapy 268Bevacizumab 230Dexamethasone 217fludarabine 205Docetaxel 190durvalumab 188venetoclax 187Oxaliplatin 187Rituximab 174Fluorouracil 174atezolizumab 169Pemetrexed 166Capecitabine 162Radiosurgery 160Doxorubicin 160Radiation 156Ipilimumab 144Lenalidomide 140Leucovorin 138Etoposide 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Endoscopic Mucosal Resection × 90 days × Clear all
NCT06815406 2026-05-06

ESD vs EMR

Azienda USL Reggio Emilia - IRCCS

Phase NA Recruiting
282 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03641313 2026-04-13

Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
17 enrolled 14 charts
Gastrointestinal

Clinical Stage III Gastric Cancer AJCC v8

NCT04919824 2026-03-24

Monopolar Current Cutting Knife vs Bipolar RFA Knife

Baylor College of Medicine

Phase NA Active not recruiting
80 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

NCT06134687 2026-03-24

Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection

Baylor College of Medicine

Phase NA Recruiting
66 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

NCT06159634 2026-03-24

Traction vs. No Traction in Colonic ESD

Baylor College of Medicine

Phase NA Recruiting
150 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

NCT05078866 2026-03-03

Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients

National Cancer Institute (NCI)

Phase 1/2 Active not recruiting
45 enrolled
Gastrointestinal

Colorectal Neoplasms, Hereditary Nonpolyposis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡